اثرات محافظتی بر استخوان متعاقب تجویز عصاره الکلی گیاه گلدر (Otostegia persica) در موش‌های دیابتی شده توسط استرپتوزوتوسین: مطالعه هیستومورفومتری

Alghadyan, A.A., (2011) Diabetic retinopathy - An update. Saudi J Ophthalmol. 25: 99-111.

Altan, M.F., Kanter, M., Donmez, S., Kartal, M.E., Buyukbas, S. (2007) Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats. Acta Histochem. 109: 304-314.

Andallu, B., Varadacharyulu, N.C. (2003) Anti-oxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats. Clini ca Chim Acta. 338: 3-10.

Babu, P.S., Srinivasan, K. (1997) Influence of dietary capsaicin and onion on the metabolic abnormalities associated with streptozotocin induced diabetes mellitus. Mol Cell Biochem. 175: 49-57.

Bain, S., Ramamurthy, N.S., Impeduglia, T., Scolman, S., Golub, L.M., Rubin, C. (1997) Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone. 21: 147-153.

Dennison, E.M., Cooper, C., Cole, Z.A. (2009) Early development and osteoporosis and bone health. J Dev Orig Health Dis. 1: 142-149.

Deyhim, F., Mandadi, K., Patil, B.S., Faraji, B. (2008) Grapefruit pulp increases antioxidant status and improves bone quality in orchidectomized rats. Nutrition. 24: 1039-1044.

Deyhim, F., Garica, K., Lopez, E., Gonzalez, J., Ino, S., Garcia, M., Patil, B.S. (2006) Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition.  22: 559-563.

Ebrahimpoor, M.R., Khaksar, Z., Noorafshan, A. (2010) Anti-diabetic effect of orally administered Otostegia persica extract on streptozotocin diabetic rats. Comp Clin Pathol. 20: 523-525.

Garrett, I.R., Boyce, B.F., Oreffo, R.O., Bonewald, L., Poser, J., Mundy, G.R. (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest. 85: 632-639.

Hamada, Y., Fujii, H., Fukagawa, M. (2009) Role of oxidative stress in diabetic bone disorder. Bone. 45: 35-38.

Hunter, F, Kayne, S.B (2004) Veterinary Pharmaco-logy. (1st ed.) Pharmaceutical Press. London. UK.

Iwamoto, J., Seki, A., Sato, Y., Matsumoto, H., Takeda, T., Yeh, J.K. (2010) Vitamin K2 Prevents Hyperglycemia and Cancellous Osteopenia in Rats with Streptozotocin-Induced Type 1 Diabetes. Calcif Tissue Int. 88: 162-168.

Jeffcoate, W.J., Harding, K.G. (2003) Diabetic foot ulcers. Lancet. 361: 1545-1551.

Kim, H.J., Chang, E.-J., Kim, H.-M., Lee, S.B., Kim, H.-D., Su Kim, G., Kim, H.-H. (2006) Antioxidant a-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-|k|B DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kB ligand and tumor necrosis factor-a. Free Radic Biol Med. 40: 1483-1493.

Laffel, L. (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes/ Metab Res Rev. 15: 412-426.

Lean, J.M. (2004) Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology. 146: 728-735.

Lean, J.M., Davies, J.T., Fuller, K., Jagger, C.J., Kirstein, B., Partington, G.A., Urry, Z.L., Chambers, T.J. (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 112: 915-923.

Lelovas, P.P., Xanthos, T.T., Thoma, S.E., Lyritis, G.P., Dontas, I.A. (2008) The laboratory rat as an animal model for osteoporosis research. Comp Med. 58: 424-430.

Mandadi, K., Ramirez, M., Jayaprakasha, G.K., Faraji, B., Lihono, M., Deyhim, F., Patil, B.S. (2009) Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine. 16: 513-520.

Maniam, S., Mohamed, N., Shuid, A.N., Soelaiman, I.N. (2008) Palm tocotrienol exerted better antioxidant activities in bone than a-tocopherol. Basic Clin Pharmacol Toxicol. 103: 55-60.

Manzari-Tavakoli, A., Pouraboli, I., Yaghoobi, M.-M., Mehrabani, M., Mirtadzadini, S.-M. (2013) Antihyperglycemic, antilipid peroxidation, and insulin secretory activities of Otostegia persica shoot extract in streptozotocin-induced diabetic rats and in vitro C187 pancreatic b-cells. Pharm Biol. 51: 253-259.

Melhus, H.A., Michaëlsson, K., Holmberg, L., Wolk, A., Ljunghall, S. (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res. 14: 129-135.

Merlotti, D., Gennari, L., Dotta, F., Lauro, D., Nuti, R. (2010) Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr, Metab Cardiovasc Dis. 20: 683-690.

Mishima, N., Sahara, N., Shirakawa, M., Ozawa, H. (2002) Effect of streptozotocin-induced diabetes mellitus on alveolar bone deposition in the rat. Arch Oral Biol. 47: 843-849.

Muthusami, S., Ramachandran, I., Muthusamy, B., Vasudevan, G., Prabhu, V., Subramaniam, V., Jagadeesan, A., Narasimhan, S. (2005) Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta. 360: 81-86.

Najafian, B., Mauer, M. (2009) Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract. 83: 1-8.

Nicodemus, K.K., Folsom, A.R. (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 24: 1192-1197.

Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M., Recker, R.R. (1987) Bone histomorphometry: standardiz-ation of nomenclature, symbols, and units: report of the ASBMR histomorphometry nomenclature com-mittee. J Bone Miner Res. 2: 595-610.

Pousti, I., Adibmoradi, M. (2006) Histotechnique, Histotechnique, University of Tehran press. (1st ed.) Tehran, Iran.

Schwartz, A.V. (2003) Diabetes mellitus: does it affect bone?. Calcif Tissue Int. 73: 515-519.

Sharififar, F., Mozaffarian, V., Moradkhani, S. (2007) Comparison of antioxidant and free radical scavenging activities of the essential oils from flowers and fruits of Otostegia persica Boiss. Pak J Biol Sci. 10: 3895-3899.

Shen, C.L., Wang, P., Guerrieri, J., Yeh, J.K., Wang, J.S. (2007) Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int. 19: 979-990.

Shomali, T., Rezaian, M., Rassouli, A., Asadi, F. (2009) Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats. Basic Clin Pharmacol Toxicol. 105: 46-50.

Singab, A.N.B., El-Beshbishy, H.A., Yonekawa, M., Nomura, T., Fukai, T. (2005) Hypoglycemic effect of Egyptian Morus alba root bark extract: Effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J Ethnopharmacol. 100: 333-338.

Stehouwer, C.D.A., Lambert, J., Donker, A.J.M., van Hinsbergh, V.W.M. (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 34: 55-68.

Tsuchida, T., Sato, K., Miyakoshi, N., Abe, T., Kudo, T., Tamura, Y., Kasukawa, Y., Suzuki, K. (2000) Histomorphometric evaluation of the recovering effect of human parathyroid hormone on bone structure and turnover in streptozotocin-induced diabetic rats. Calcif Tissue Int. 66: 229-233.

Verhaeghe, J., Roger, B. (2008)  Effects of diabetes and insulin on bone physiology. In: Principles of Bone Biology. (3rd ed.) Academic Press. London, UK. p. 983-999.

Wild, S., Roglic, G., Green, A., Sicree, R., King, H. (2004) Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 27: 1047-1053.

Willatgamuwa, S.A., Platel, K., Saraswathi, G., Srinivasan, K. (1998) Antidiabetic influence of dietary cumin seeds (Cuminum cyminum) in streptozotocin induced diabetic rats. Nutr Res. 18: 131-142.

Williams, B., Gallacher, B., Patel, H., Orme, C. (1997) Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes. 46: 1497-1503.

Williamson, J.R., Chang, K., Frangos, M., Hasan, K.S., Ido, Y., Kawamura, T., Nyengaard, J.R., van Den Enden, M., Kilo, C., Tilton, R.G. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42: 801-813.

Wiwanitkit, V. (2006) Formation of fructosamine in diabetic patients-what are implications in terms of energy exchange. Diabetol Croat. 35: 35-37.